Medtronic (MDT): Gradient Investments LLC added to its stake +12K shares
Gradient Investments LLC added to its stake in Medtronic, per its Q3 2025 13F.
- 463K
- Shares reported · +12K vs prior quarter
- 0.74%
- Disclosed portfolio weight
- $44.1M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Oct 6, 2025
What stands out in this filing
- 451,679 shares in Q2 2025, 463,263 now (+2.6% in share count).
- Reported at $44.1M, 0.74% of the portfolio value in this 13F filing.
- 68 other tracked managers reported the same kind of change for Q3 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 15, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Aug 14, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Aug 22, 2025InsiderDirector purchased ~$232K of MDT shares in the open market
- Aug 25, 2025InsiderDirector purchased ~$231K of MDT shares in the open market
- Sep 3, 2025Insider · 1 personInsiders: 2 sales (~$788K)
- Sep 29, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
What came next
- Oct 16, 2025Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
- Nov 1, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 1, 2025, Gregory L. Smith, Executive Vice President, Enterprise Operations of Medtronic plc (the Company), notified the Company of his decision to retire from the Company, effective December 2, 2025, and to join a private equity-held organization.”
- Nov 5, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Nov 13, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Nov 18, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 19, 2025Insider · 1 personInsiders: 7 sales (~$3.1M)
- Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.2%
- Dec 18, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Dec 29, 2025FDAFDA device clearance: Shiley Adult Flexible Tracheostomy Tube XLT with TaperGuard Cuff, Distal with Disposable Inner Cannula; Shiley Adult Flexible Tracheostomy Tube XLT with Tap…
- Jan 7, 2026FDAFDA device clearance: CD Horizon ModuLeX Spinal System (LigaMAS Head Assembly)
- Jan 8, 2026FDAFDA device clearance: MiniMed Go App
- Jan 13, 2026FDARecall: Octopus Nuvo Tissue Stabilizer, disposable tissue stabilization system, Product Number TSMICS1
- Jan 14, 2026FDAFDA device clearance: SmartGuard technology; Predictive Low Glucose technology
- Jan 14, 2026FDAFDA device clearance: Concerto Versa Detachable Coil
- Jan 15, 2026FDAFDA device clearance: MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894)
- Jan 15, 2026FDAFDA device clearance: Bio-Medicus Life Support Catheter and Introducer
- Jan 16, 2026FDAFDA device clearance: Affinity Pixie Arterial Filter with Balance Biosurface; Affinity® Pediatric Arterial Blood Filter
- Jan 17, 2026FDAFDA device clearance: Sprinter Legend Rapid Exchange Balloon Dilatation Catheter
- Jan 20, 2026FDAFDA device clearance: Clearview Intracoronary Shunts
- Jan 21, 2026FDAFDA device clearance: Infinity OCT System
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
How this filing works
Explore the data
Common questions
What does this filing report about Medtronic (MDT) stock?
Gradient Investments LLC added to its stake in Medtronic, per its Q3 2025 13F. Now 463K shares, $44.1M reported value, 0.74% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Sep 30, 2025. Filed: Oct 6, 2025.
What stands out in this filing?
451,679 shares in Q2 2025, 463,263 now (+2.6% in share count). Reported at $44.1M, 0.74% of the portfolio value in this 13F filing. 68 other tracked managers reported the same kind of change for Q3 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Medtronic recently?
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.
Does this mean MDT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
